Yuan-Hong Xu Selected Research

Yuan-Hong Xu Research Topics

2	Inflammation (Inflammations) 06/2022 - 04/2017
2	Chronic Obstructive Pulmonary Disease (COPD) 06/2022 - 01/2015
1	Infections 06/2022
1	Extensively Drug-Resistant Tuberculosis 05/2020
1	Muscular Atrophy (Muscle Atrophy) 04/2019
1	Vulvovaginal Candidiasis 04/2017
1	Sepsis (Septicemia) 02/2017
1	Syphilis 01/2016
1	Stomach Neoplasms (Stomach Cancer) 01/2016
1	Chronic Hepatitis B 05/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2015
1	Toxoplasmosis 08/2013
1	Parasitemia 08/2013
1	Body Weight (Weight, Body) 08/2013
1	Intussusception 07/2009

2	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2016
1	InflammasomesIBA 06/2022
1	InterleukinsIBA 06/2022
1	Messenger RNA (mRNA)IBA 06/2022
1	CytokinesIBA 06/2022
1	Small Interfering RNA (siRNA)IBA 06/2022
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 06/2022
1	Antitubercular AgentsIBA 05/2020
1	Pharmaceutical PreparationsIBA 05/2020
1	UbiquitinIBA 04/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2019
1	CaspasesIBA 04/2019
1	Matrix Metalloproteinases (MMPs)IBA 04/2019
1	Vitamin B Complex (B Vitamins)IBA 04/2017
1	ProcalcitoninIBA 02/2017
1	Biomarkers (Surrogate Marker)IBA 02/2017
1	C-Reactive ProteinIBA 02/2017
1	Immunoglobulin G (IgG)IBA 01/2016
1	Immunoglobulin M (IgM)IBA 01/2016
1	AntibodiesIBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	InterferonsIBA 05/2015
1	Hepatitis B e AntigensIBA 05/2015
1	CalciumIBA 01/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2013
1	pidotimodIBA 08/2013

1	Therapeutics 04/2017
1	Length of Stay 01/2015
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 07/2009